Bioptamers is a startup based in the United States, 1 tracked investor.
Based in the United States, Bioptamers is a startup. Brouky records 1 investor associated with the company.
Bioptamers develops personalized precision cancer therapies through a microfluidic platform that selects synthetic aptamer molecules designed to specifically target cancer cells and deliver therapeutic interventions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.